GLPwatch
Papers (10588)
Page 177 of 177, ranked by citation count.
- The Periprocedural Safety of Continued GLP-1 Receptor Agonist Prior to Cardiac Catheterization.
- Glycemic and Economic Outcomes in Elderly Patients with Type 2 Diabetes Initiating Dulaglutide Versus Basal Insulin in a Real-World Setting in the United States: The DISPEL-Advance Study.
- Patterns of Use for GLP-1 Receptor Agonists in a Weight Management Cohort: A Military Health System Database Analysis of Active Duty Service Members From 2021 to 2025.
- Insulin Sensitivity and Beta Cell Function With Macupatide Alone or With Dulaglutide in Type 2 Diabetes: A Phase 1b, Randomised Controlled Trial.
- Liraglutide for Adolescents with Obesity.
- Use of second-generation incretin analogs (GLP-1 and GIP receptor agonists) in type 1 diabetes and latent autoimmune diabetes in adults: A systematic review.
- The role of nursing care in the type 2 diabetes treatment associated with chronic liver diseases.
- [Oral semaglutide, first oral GLP-1 receptor agonist (Rybelsus®)].
- Real-world Impact of GLP-1 Receptor Agonists on Health-related Quality of Life in Type 2 Diabetes and Obesity (SEVERAL Study).
- Optic Ischaemic Neuropathy in Incretin-Based Therapy: A Comparative Analysis of Real-World Safety Data.
- JPEN Journal Club 88. Determining the hypothesis of a study.
- Association of GLP-1 receptor agonists with alcohol use disorder-related and substance use disorder-related hospital admissions during treatment and after discontinuation: a Swedish register-based within-individual observational study.
- Incretin-Based Therapies in Doxorubicin-Induced Cardiotoxicity: A Systematic Review of GLP-1 and Dual GIP/GLP-1 Agonists.
- [Does a higher dose of oral semaglutide treatment make sense?]
- Prescription Sequence Symmetry Analysis of Glucagon-Like Peptide-1 Receptor Agonists and Neuropsychiatric Conditions.
- Effect of Tirzepatide on Health-Related Quality of Life in Japanese Patients With Obesity Disease: Patient-Reported Outcomes From the SURMOUNT-J Study.
- GLP-1 receptor agonist adjunct therapy stabilises Ramadan dysglycaemia in insulin-treated diabetes: a CGM-based study.
- Cardiovascular outcomes of semaglutide and tirzepatide in type 2 diabetes mellitus and obesity: a systematic review and meta-analysis.
- [Conserved W52 led to reduced binding of glucogan-like peptide 1 receptor].
- In early T2D inadequately controlled with diet and exercise, once-daily orforglipron reduced HbA<sub>1c</sub> vs. placebo at 40 wk.
- [Liraglutid can support weight loss].
- Semaglutide Once Weekly Helps Adolescents Lose Weight, but 4% Developed Acute Cholelithiasis.
- Development of novel radioiodinated exendin-4 derivatives targeting GLP-1 receptor for detection of β-cell mass.
- Glucagon-like Peptide-1 Receptor Agonists as a Dual-target Strategy for Depression and Metabolic Health: A Narrative Review.
- Semaglutide in people with HIV-associated lipohypertrophy.
- Comment on Effect of Swallow Balloon Therapy with the Combination of Semaglutide Oral Formulation: a Randomised Double‑Blind Single‑Centre Study.
- Any expectations from the more powerful dulaglutide?
- Drug-Associated Ketoacidosis: A Comprehensive Disproportionality Analysis Based on the FAERS Database.